Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
SIGNAL TRANSDUCTION

Kinetic Analysis of Smad Nucleocytoplasmic Shuttling Reveals a Mechanism for Transforming Growth Factor β-Dependent Nuclear Accumulation of Smads

Bernhard Schmierer, Caroline S. Hill
Bernhard Schmierer
Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline S. Hill
Laboratory of Developmental Signalling, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Caroline.Hill@cancer.org.uk
DOI: 10.1128/MCB.25.22.9845-9858.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Characterization of the cell lines used. Whole-cell extracts were subjected to immunoblotting with antibodies as indicated. A. Parental cells (HaCaT) and cell lines expressing PAGFP (PAGFP), PAGFP-tagged Smad2 (PAS2) and EGFP-tagged Smad2 (ES2). PAGFP alone is highly expressed, PAGFP-Smad2 and EGFP-Smad2 are both expressed at levels comparable to endogenous Smad2 and are readily phosphorylated in response to 1 h treatment with 2 ng/ml TGF-β (Tβ). B. EGFP-Smad2 phosphorylation exhibits a very similar kinetics as endogenous Smad2 phosphorylation in response to TGF-β. Upon addition of SB-431542 to cells that have been pretreated with TGF-β, EGFP-Smad2 and endogenous Smad2 become dephosphorylated with highly similar kinetics. C. Cell lines expressing PAGFP-Smad4 (PAS4) and EGFP-Smad4 (ES4). Both proteins are expressed at approximately endogenous levels.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Compartment-specific photoactivation of PAGFP-Smad2. Cells are shown directly before photoactivation (B/A), and 0, 1, 5, and 12 min after a 10- to 20-second photoactivation of a specific compartment. The shaded area in the phase contrast pictures indicates the actual photoactivation area. A. Nuclear photoactivation of PAGFP-Smad2 by repeatedly scanning an area containing the nucleus in cells treated for 15 min with SB-431542 (i) or cells induced for 1 h with TGF-β (ii). In SB-431542-treated cells, PAGFP-Smad2 photoactivated in the nucleus accumulates in the cytoplasm, reaching a distribution typical for an uninduced cell. Despite strong nuclear accumulation in TGF-β-treated cells, a significant proportion of PAGFP-Smad2 becomes visible in the cytoplasm with increasing time. B. Cytoplasmic photoactivation by scanning an area comprising the whole cytoplasm but excluding the nucleus. (i) SB-431542-treated cells quickly reach a steady-state distribution typical for uninduced cells. In TGF-β-treated cells, which have reached a state of maximal accumulation prior to photoactivation, cytoplasmically photoactivated PAGFP-Smad2 still accumulates in the nucleus, provided the receptors are active (ii), but not if receptors have been inactivated by SB-431542 added 90 min after the TGF-β and 10 min before photoactivation (iii). Pictures show representatives from at least 3 independent experiments.

  • FIG.3.
    • Open in new tab
    • Download powerpoint
    FIG.3.

    Import and export rate constants. A. Nuclei of SB-431542-treated cells expressing EGFP-Smad2 (i) or EGFP-Smad2 ΔMH1 (ii) were photobleached. The reappearance of nuclear fluorescence in the nucleus and the fluorescence loss in the cytoplasm were monitored until a steady state was reached. Alternatively, the cytoplasm of untreated, PAGFP-expressing cells was photoactivated (iii) and the redistribution of fluorescence was monitored as above. In the graphs, circles represent experimental points and solid lines are theoretical curves derived from the experimental data, assuming first-order kinetics. From the curves, import rate constants and export rate constants were calculated (see Fig. S1 in the supplemental material). Pictures show representative experiments with fluorescence perturbation performed in either 1 cell (i) or two cells (ii and iii). B. Import and export rate constants obtained for EGFP-Smad2, EGFP-Smad2 ΔMH1 and PAGFP. Bars show means ± standard deviations (n = 10).

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Nucleocytoplasmic distribution of EGFP-Smads in induced and uninduced cells. A. EGFP-Smad2 cells and EGFP-Smad4 cells were induced with TGF-β for 1 h or were treated with SB-431542. Pictures show representative images for each condition. B. Mean fluorescence intensities of the nucleus (Fn) and the cytoplasm (Fc) were measured and the fluorescence ratio R was calculated. Bars show means ± standard deviations, n was 30 for each condition. C. Using R and an average ratio A between accessible cytoplasmic and accessible nuclear volume of 2.9 as obtained from kinetic experiments (Fig. 3 and Fig. S1 in the supplemental material), relative amounts of EGFP-Smad in the cytoplasm and nucleus of uninduced cells were calculated. Moreover, we estimated the relative fraction of EGFP-Smad that is nuclear in response to TGF-β. For details see the text. Values are given as a percentage of total cellular EGFP-Smad.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    TGF-β stimulation affects the export rate of the Smads, but not the import rate. A. Cell lines expressing PAGFP-Smad2 and PAGFP-Smad4 were treated for 1 h as indicated and entire nuclei were photoactivated for 5 to 10 seconds. Loss of nuclear fluorescence due to export was monitored for 60 seconds after photoactivation. Data were normalized to the initial nuclear fluorescence directly after photoactivation and an initial export rate was obtained. Bars represent mean values and standard deviations obtained from 20 cells for each condition. Note that the export rate for Smad2 in unstimulated cells agrees well with the export rate constant obtained in Fig. 3. B. Nuclear import. Entire nuclei of EGFP-Smad2 cells were photobleached. Nuclear fluorescence immediately after the bleach was set to zero and reappearance of nuclear fluorescence was measured. Values were normalized for expression levels, each curve represents a single cell. (i) Initial nuclear import in SB-431542-treated cells (blue curves) and cells treated with TGF-β for between 10 and 40 min, i.e., during the actual accumulation phase before establishment of a steady state (red curves). (ii) Nuclear import in cells treated for 1 h with SB-431542 (blue curves) and cells treated for 1 h with TGF-β and hence having reached a steady state of nuclear accumulation (red curves).

  • FIG.6.
    • Open in new tab
    • Download powerpoint
    FIG.6.

    Assessment of Smad mobilities in the nucleus and cytoplasm by FRAP. FRAP was performed on EGFP-Smad2- and EGFP-Smad4-expressing cells treated for 1 h with SB-431542 (SB), TGF-β or LMB. The curves represent data from 10 cells in each case. A. Nuclear recovery curves for EGFP-Smad2 (left panel) and EGFP-Smad4 (right panel). For comparison, the much faster recovery of photoactivated PAGFP, which is thought to be exclusively due to diffusion is shown. B. Cytoplasmic recovery curves of EGFP-Smad2 (left panel) and EGFP-Smad4 (right panel) in cells treated as indicated. Recovery of photoactivated PAGFP is shown for comparison. C. Recovery half-times, i.e., time after which the corresponding recovery curve has reached 0.5.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Schematic model of Smad nucleocytoplasmic transport. For details, refer to the text. Red oval, phosphate group. NPC, nuclear pore complex. TF, transcription factor. TβR-I, TGF-β receptor type I. TβR-II, TGF-β receptor type II.

Additional Files

  • Figures
  • HTML Page - index.htslp

    Files in this Data Supplement:

    • Supplemental file 1 - Fig. S1 (Derivation of modeling equations and volume ratios obtained for different proteins), S2 (EGFPSmad2 proteins), and S3 (EGFPSmad2 accumulation)
      Zipped PDF document, 347K.
PreviousNext
Back to top
Download PDF
Citation Tools
Kinetic Analysis of Smad Nucleocytoplasmic Shuttling Reveals a Mechanism for Transforming Growth Factor β-Dependent Nuclear Accumulation of Smads
Bernhard Schmierer, Caroline S. Hill
Molecular and Cellular Biology Oct 2005, 25 (22) 9845-9858; DOI: 10.1128/MCB.25.22.9845-9858.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Kinetic Analysis of Smad Nucleocytoplasmic Shuttling Reveals a Mechanism for Transforming Growth Factor β-Dependent Nuclear Accumulation of Smads
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Kinetic Analysis of Smad Nucleocytoplasmic Shuttling Reveals a Mechanism for Transforming Growth Factor β-Dependent Nuclear Accumulation of Smads
Bernhard Schmierer, Caroline S. Hill
Molecular and Cellular Biology Oct 2005, 25 (22) 9845-9858; DOI: 10.1128/MCB.25.22.9845-9858.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Cell Nucleus
Cytoplasm
Smad Proteins
Smad2 Protein
Transforming Growth Factor beta

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549